Life sciences

  • Researchers kill bugs with nanoparticles

    Researchers have developed a new technology, based on nanoparticles, to kill dangerous bacteria that hide inside human cells. Burkholderia is a genus of bacterium that causes a deadly disease called melioidosis. This disease kills tens of thousands of people each year, particularly in southeast Asia. Antibiotics administered orally or intravenously often don’t work very well [...]

  • Tool to assess threat of new Omicron variant

    Imperial College London’s COVID-19 Response Team has developed a new tool to assess the threat of new variants, including the new Omicron variant, in real-time. The MV-EpiEstim tool (MV: multivariant) can be used to estimate the transmission advantage of the new Omicron COVID-19 variant. The team say that the method can be a useful tool for [...]

  • Groundbreaking drug discovery could lead to new Alzheimer’s treatments

    Scientists have made a breakthrough discovery that could advance the treatment of Alzheimer’s Disease. Researchers from the University of Glasgow and the biotechnology company Sosei-Heptares Ltd, have designed a new molecule that selectively targets a specific receptor protein in the brain. Professor Andrew Tobin, professor of molecular pharmacology at the University of Glasgow, said the [...]

  • NetScientific invests $1m in bone reconstruction company EpiBone

    Life sciences investment group NetScientific plc has invested a further $1m into EpiBone Inc, a regenerative medicine company that focuses on bone and cartilage reconstruction based in the US. The investment comprises of $734k from NetScientific’s balance sheet and $266k in advised funds from the group’s corporate finance and venture capital subsidiary EMV Capital Ltd. [...]

  • Microscope uses photonics to gain insights into ‘superbugs’

    Technology platform Photonics21 is building a super-resolution microscope that uses laser light to study the inner workings of superbugs. Scientists say the NanoVIB microscope will allow users to look into bacteria, such as Streptococcus Pneumoniae, at a molecular-scale resolution, showing up objects smaller than 10,000th the thickness of a sheet of paper, to gain new insights [...]

  • Interview: Ending the haemophilia drug shortage

    Jaymin Amin, CEO of ProFactor Pharma (PFP), discusses the company's life-changing, and life-saving, work. PFP says it has developed a low-cost production process for creating human factor VIII (rhFVIII), a complex protein which induces blood clotting and is used to treat haemophilia A. There is a severe worldwide shortage of rhFVIII and PFP has developed a patent [...]

  • Using gold to reduce antibiotic resistance

    Research has identified a way of using nanoclusters to bolster waning antibiotics. Tiny particles of gold could be a new weapon in the fight against bacterial antibiotic resistance, research by an international  team of scientists has revealed. Scientists have been investigating the use of gold nanoclusters, each made up of 25 atoms of gold, to [...]

  • New stroke clot-buster drug shows ‘exciting potential’

    A novel clot-busting drug formulated and tested by University of Manchester scientists is able to effectively restore blood flow in the brains of mice, opening the door for a safer and more effective stroke treatment. The compound, an enzyme called caADAMTS13, could dissolve clots in patients that are resistant to current treatment, according to the [...]

  • University programme for next generation of bio scientists

    Teesside University, based in North East England, has launched a programme to show students what a career in the life sciences could look like. The first cohort of the Life Sciences Manufacturing Academy saw students from Darlington College spending a week at Teesside University’s National Horizons Centre, hearing from their biotech experts, and colleagues from [...]

  • Has the life sciences industry reached a technological turning point?

    Andrew Martin, senior sales and marketing director at EMEA and managing director UK at Egnyte, discusses the fastest growing trends in biotech. With the life sciences industry slowly ramping back up to pre-pandemic activity levels, the uncertainty of the last 18 months is starting to lift. As it does , we are seeing an acceleration of [...]